CLINICAL_TRIALS
trial_result
· 2025-11-12
Clinical Trial Update: Study of TDM-105795 Following Topical Administration in Male Subjects With Androgenetic Alopecia [Phase 2]
Summary
Phase 2 study evaluating the topical agent TDM-105795 for androgenetic alopecia in men has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Technoderma Medicines Inc. | Conditions: Alopecia, Androgenetic | Phase 2 | Status: COMPLETED | Results posted: 2025-11-12